Impact of Bariatric Surgery on Epicardial Adipose Tissue and on Myocardial Function

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

44 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Growing evidence suggests that bariatric surgery is a relevant treatment for severely obese patients, especially those with metabolic complications, as it significantly reduces weight, hypertension and ameliorates glycemic control. Its action on adipose tissue distribution and in particular on epicardial adipose tissue EAT remains unknown. Whether metabolic improvement is associated with EAT reduction is also unknown.

The researchers thus investigated the effect of bariatric surgery on EAT in severely obese patients. The primary endpoint of this study was the change in EAT amount 6 months after bariatric surgery.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Impact of Bariatric Surgery on Heart Disease Compared to Standard Care

NCT06346145

Obesity, Morbid Bariatric Surgery Candidate Heart Diseases

NOT_YET_RECRUITING NA

Diastolic Dysfunction in Morbidly Obese Patients Undergo Bariatric Surgery

NCT04128735

Diastolic Dysfunction Morbid Obesity

COMPLETED

Effect of Bariatric Surgery on Cardiac Function in Patients With Hypertension

NCT05166954

Bariatric Surgery Hypertension

RECRUITING

Effects of Various Bariatric Surgical Procedures on Intestinal Triglyceride-rich-lipoprotein (TRL) Metabolism in Obese Patients

NCT01277068

Obese Patients Production Rates of These TRL Before and After the Bariatric Surgery Cardiovascular Diseases

COMPLETED NA

Role of Dietary Habits in Efficacy of Bariatric Surgery - Study A

NCT03470558

Bariatric Surgery Sleeve Gastrectomy Obesity

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The best of our knowledge, no study has really addressed whether this EAT was modulated by diet or therapeutics like bariatric surgery. The researchers were particularly interested in studying the impact of bariatric surgery and of weight loss on the amount of EAT and whether reduction in EAT could have a positive impact on myocardial function.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Severely Obese Patients

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Intervention Model

CROSSOVER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

severely obese patients

35 patients addressed for severe obesity in the Endocrinology department of Marseille North Hospital before (V1) and 6 months (V2) after bariatric surgery

Group Type OTHER

bariatric surgery

Intervention Type PROCEDURE

The bariatric surgery is a relevant treatment for severely obese patients those with metabolic complications, as it significantly reduces weight, hypertension and ameliorates glycemic control.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

bariatric surgery

The bariatric surgery is a relevant treatment for severely obese patients those with metabolic complications, as it significantly reduces weight, hypertension and ameliorates glycemic control.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* men or women who have more than 18 years
* patients have been informed and have consented
* severely obese patients with surgery indication

Exclusion Criteria

* contraindications at surgery, at MNR imagery
* History of infarct, of congenital cardiomyopathy
* Treatment modifying the distribution of the fat
* Pregnant or breast-feeding women
* patients less than 18 years
* Patient without consentment

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No